Latest News

Dec 13, 2007

Health Enhancement Products signs contract with Specialty Nutrition Group, Inc for Re-Branding and Product Marketing of ProAlgaZyme.


Nov 14, 2007

Health Enhancement Products Announced the Long Awaited Discovery of a Class of "Orally Active Agents" in Its Primary Product, ProAlgaZyme


Nov 6, 2007

Health Enhancement Products Reports Results in the Second Testing of the ProAlgaZyme Clinical Lot Used in the Suspended Clinical Trial


Oct 25, 2007

Health Enhancement Products Reports Results in Testing of the ProAlgaZyme Clinical Lot Used in the Suspended Clinical Trial



Health Enhancement Products is a member of these organizations







 

Health Enhancement Products, Inc. and HEPI Pharmaceuticals, Inc. Announce Resignation of CEO

Friday September 7, 9:30 pm ET

 
SCOTTSDALE, AZ--(MARKET WIRE)--Sep 7, 2007 -- Health Enhancement Products, Inc. (OTC BB:HEPI.OB - News) and HEPI Pharmaceuticals, Inc., its wholly owned subsidiary, announced today that Thomas D. Ingolia has resigned as director and CEO of the companies. Effective immediately Janet Crance, currently a director and the Chief Accounting Officer of each company, will act as the Chief Administrative Officer of both companies.

About Health Enhancement Products, Inc. and ProAlgaZyme

Health Enhancement Products Inc. is a nutraceutical company engaged in the development of a Dietary Supplement product using only pure, all-natural ingredients. The company's sole product is ProAlgaZyme, a liquid product produced from algae grown in 100% distilled water. The liquid in which the algae are grown is drawn off, filtered, tested and bottled as ProAlgaZyme. HEPI Pharmaceuticals, Inc. is exploring the development of the potential pharmaceutical applications of ProAlgaZyme.

For more information, please visit www.heponline.com.

Contact information:

John Gorman
Email Contact
480-385-3800

 

<< Back to Releases

 

© 2007 HEALTH ENHANCEMENT PRODUCTS INC.
            PRIVACY POLICY           DISCLAIMER 

 

v5Design.Com